- Opinion
- [Reporter’s View] Decreased vaccine funding during endemic
- by Son, Hyung-Min Apr 24, 2024 05:44am
- K-bio and Vaccine Fund No.3 is soon to be launched. Considering the recent contraction of the investment market, the entire amount of KRW 40 billion of investment money from the government and the government-run bank has been invested, regardless of the formation size. Once the initial formation of KRW 70 billion is raised, early investmen
- Opinion
- [Reporter’s View] Additions to the post-management system
- by Eo, Yun-Ho Apr 12, 2024 05:41am
- “The introduction of the post-management system aims to secure additional evidence related to medicines of uncertain safety and efficacy. The system is intended to improve healthcare by reverifying those medicines with medical knowledge.” Although the intention seems reasonable, some are voicing concerns. The concern is that reinforci
- Opinion
- [Reporter’s View] Delays in reimbursement listing
- by Lee, Tak-Sun Apr 9, 2024 05:50am
- Last January, the Health Insurance Review and Assessment Service (HIRA) posted a document explaining the delay in listing and related press reports. The message was that the HIRA strives to implement faster listing, but pharmaceutical companies must cooperate. “Pharmaceutical companies must submit relevant documents for drugs subject
- Opinion
- [Reporter’s View] Results needed for ‘Ilaris’ on hold
- by Eo, Yun-Ho Apr 1, 2024 05:29am
- It made its third attempt, but Ilaris faced another challenge. ‘Ilaris,’ a drug for about ten patients in South Korea, has not cleared the Drug Reimbursement Evaluation Committee (DREC) of the Health Insurance Review and Assessment Service (HIRA) and is on hold. Novartis Korea’s Ilaris (canakinumab), a drug used to treat periodic fever
- Opinion
- [Reporter’s View] Let Enhertu’s case guide new listings
- by Eo, Yun-Ho Mar 19, 2024 05:44am
- The reimbursement listing of the advanced ADC anti-cancer drug Enhertu is imminent. The company completed drug pricing negotiations with the National Health Insurance Service at a ‘superfast’ speed when considering the slow progress it had made during previous procedures. At this pace, Enhertu is likely to be reimbursed in April this year.
- Opinion
- [Reporter’s View] 'Tylenol,' no longer produced,
- by Lee, Hye-Kyung Mar 18, 2024 05:49am
- Twelve years have passed since the government desginated over-the-counter emergency medicines. On November 15, 2012, the government implemented 13 over-the-counter (OTC) emergency medicines, including antipyretic analgesics, gastrointestinal medicine, and patches. When designating 13 OTC emergency medicines, the government based its eval
- Opinion
- [Reporter’s View] Biotech’s confidence and responsibility
- by Son, Hyung-Min Mar 14, 2024 05:42am
- Several biotechnology companies in South Korea have suffered major setbacks while pursuing first-in-class new technology businesses. GenNBio, a company known for xenotransplantation of pancreatic islets, is currently facing the possibility of being dissolved. Due to management disputes, the departure of key R&D personnel, financial diffic
- Opinion
- [Reporter’s View] Need momentum to boost investments
- by Kim, Jin-Gu Mar 12, 2024 05:49am
- Investment in the domestic pharma-bio industry is slowly rising, awakening from its long winter slumber. Although it is still too early to call it a full spring compared to the boom the industry had enjoyed in 2021-2022, however, significant signs of recovery are being shown through various indicators. Such change is usually most often n
- Opinion
- [Reporter’s View] Potential drawbacks of expanding RSAs
- by Lee, Tak-Sun Mar 12, 2024 05:49am
- It has been announced that more drugs will be added to the Risk Sharing Agreements (RSAs) track, which will help to improve patient access and reduce uncertainties. In December, the ‘Improvement of the Drug Pricing System to Ensure Fair-value Compensation for Innovative New Drugs and Healthcare Security’ was announced. Under this syste
- Opinion
- [Reporter’s View] On MFDS’s new drug management team
- by Lee, Hye-Kyung Mar 6, 2024 06:03am
- A new drug management support team will be established under the Ministry of Food and Drug Safety’s Pharmaceutical Safety Bureau. According to the 'Partial Amendment of the Enforcement Rules of the Ministry of Food and Drug Safety and its Affiliated Institutions' that was released by the MFDS on February 7, the MFDS will newly establish a d
